Abstract Impaired cell proliferation causes fibrotic changes in tissues, leading to loss of function. Although exocyst component 5 (Exoc5), a central component of the eight-protein exocyst complex, regulates the targeting and docking of intracellular vesicles which are essential for cell proliferation, its role in tissue regeneration remains to be defined. Here, we investigated the role of Exoc5 in the repair of kidney injury induced by ischemia-reperfusion (I/R) using proximal tubule cell (PTC)-specific Exoc5 knockout (Exoc5 KO ) mice generated by crossing Exoc5 f/f with PEPCK-cre mice. Exoc5 KO and wild-type (Exoc5 WT ) mice were subjected to either bilateral kidney I/R or sham surgery. I/R induced functional and structural kidney damage in both Exoc5 KO and Exoc5 WT mice, as evidenced by increased plasma creatinine and BUN, decreased glomerular filtration rate, and histological damage. Kidney function and structure gradually improved in both Exoc5 KO and Exoc5 WT mice over time; however, neither group fully recovered normal function, and the recovery was less pronounced in Exoc5 KO than in Exoc5 WT mice. Twenty-one days after I/R, Exoc5 KO mice showed greater collagen deposition and α-smooth muscle actin (α-SMA) and vimentin expression compared to Exoc5 WT mice, whereas E-cadherin expression was lower. Post-I/R PTC proliferation in Exoc5 KO mice was significantly lower than in Exoc5 WT mice. In contrast, post-I/R induction of paired box 2 (Pax2) was greater in Exoc5 KO than in Exoc5 WT mice. In HK-2 cells, a human PTC line, Exoc5 downregulation by siRNA increased Pax2 expression and further increased N-cadherin, phosphorylated-Smad3 (p-Smad3), and α-SMA expression compared to control cells following TGF-β treatment. Collectively, these findings indicate that loss of Exoc5 impairs PTC regeneration and exacerbates fibrosis in the injured kidney, suggesting its therapeutic potential in preventing the transition from acute kidney injury (AKI) to chronic kidney disease (CKD).
Lim et al. (Fri,) studied this question.